Shareholder Votes

Vontier Corp shareholders approved Election of directors: Karen C. Francis, Gloria R. Boyland, Robert L. Eatroff, David M. Foulkes, Mark D. Morelli, Maryrose Sylvester and J. Darrell Thomas to serve for an annual term expiring at the 2027 Annual Meeting at the 2026-06-04 meeting.

“Proposal 1 : To elect Karen C. Francis, Gloria R. Boyland, Robert L. Eatroff, David M. Foulkes, Mark D. Morelli, Maryrose Sylvester and J. Darrell Thomas to serve for an annual term expiring at the 2027 Annual Meeting of Stockholders of the Company and until their successors are duly elected and qualified. Each of Mses. Francis, Boyland and Sylvester and Messrs. Eatroff, Foulkes, Morelli and Thomas was elected for an annual term by a vote of the Company’s stockholders as follows: For Against Abstain Broker Non-Votes Karen C. Francis 120,399,316 5,720,850 49,545 5,621,978 Gloria R. Boyland 120,327,034 5,792,894 49,783 5,621,978 Robert L. Eatroff 120,445,887 5,671,834 51,990 5,621,978 David M. Foulkes 123,758,112 2,355,323 56,276 5,621,978 Mark D. Morelli 120,440,378 5,678,758 50,575 5,621,978 Maryrose Sylvester 120,197,545 4,703,652 1,268,514 5,621,978 J. Darrell Thomas 124,223,832 1,894,339 51,540 5,621,978”

Minerva Neurosciences, Inc. shareholders approved Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 at the 2026-06-03 meeting.

“Proposal 6: Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026. The selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified. The voting results were as follows: For Against Abstain Broker Non-Votes 35,289,299 7,131 1,092 —”

Minerva Neurosciences, Inc. shareholders approved Approval, on an Advisory Basis, of the Frequency of Solicitation of Future Advisory Stockholder Approval of Named Executive Officer Compensation at the 2026-06-03 meeting.

“Proposal 5: Approval, on an Advisory Basis, of the Frequency of Solicitation of Future Advisory Stockholder Approval of Named Executive Officer Compensation. The Company’s stockholders approved Proposal 5. The voting results were as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 30,365,516 1,639 9,934 16,200 4,904,233”

Minerva Neurosciences, Inc. shareholders approved Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers at the 2026-06-03 meeting.

“Proposal 4: Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers, as disclosed in the Proxy Statement. The Company’s stockholders approved Proposal 4. The voting results were as follows: For Against Abstain Broker Non-Votes 27,183,828 3,196,678 12,783 4,904,233”

Minerva Neurosciences, Inc. shareholders approved Approval of an Amendment to our Amended and Restated Certificate of Incorporation to Eliminate the Exclusive Forum Provision at the 2026-06-03 meeting.

“Proposal 3: Approval of an Amendment to our Amended and Restated Certificate of Incorporation to Eliminate the Exclusive Forum Provision. The Company’s stockholders approved Proposal 3. The voting results were as follows: For Against Abstain Broker Non-Votes 30,360,809 20,954 11,526 4,904,233”

Minerva Neurosciences, Inc. shareholders approved Approval of an Amendment to our Amended and Restated Certificate of Incorporation to Reflect Delaware Law Provisions Allowing for the Exculpation of Certain Officers at the 2026-06-03 meeting.

“Proposal 2: Approval of an Amendment to our Amended and Restated Certificate of Incorporation to Reflect Delaware Law Provisions Allowing for the Exculpation of Certain Officers. The Company’s stockholders approved Proposal 2. The voting results were as follows: For Against Abstain Broker Non-Votes 27,222,961 3,169,756 572 4,904,233”

Minerva Neurosciences, Inc. shareholders approved Election of Directors at the 2026-06-03 meeting.

“Proposal 1: Election of Directors. Two nominees were elected to serve on the Board until the Company’s 2029 annual meeting of stockholders and until their successors are elected and qualified. The voting results were as follows: Nominee For Withheld Broker Non-Votes Dr. David Kupfer 23,211,099 7,182,190 4,904,233 Jan van Heek 30,369,333 23,956 4,904,233”

Kura Oncology, Inc. shareholders approved Approval of our Amended ESPP at the 2026-06-04 meeting.

“Proposal 6. Approval of our Amended ESPP For Against Abstain Broker Non-Votes 58,306,174 213,434 161,424 11,097,548”

Kura Oncology, Inc. shareholders approved Approval of our Amended 2014 Plan at the 2026-06-04 meeting.

“Proposal 5. Approval of our Amended 2014 Plan For Against Abstain Broker Non-Votes 48,402,820 10,099,296 178,916 11,097,548”

Kura Oncology, Inc. shareholders approved Advisory Indication on Frequency of Stockholder Advisory Votes on Executive Compensation at the 2026-06-04 meeting.

“Proposal 4. Advisory Indication on Frequency of Stockholder Advisory Votes on Executive Compensation 1 Year 2 Years 3 Years Abstain Broker Non-Votes 48,362,762 54,055 1,586,672 8,677,543 11,097,548”

Kura Oncology, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-04 meeting.

“Proposal 3. Advisory Vote on Executive Compensation For Against Abstain Broker Non-Votes 48,783,834 1,141,854 8,755,344 11,097,548”

Kura Oncology, Inc. shareholders approved Ratification of the Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“Proposal 2. Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes 69,385,497 140,763 252,320 —”

Kura Oncology, Inc. shareholders approved Election of Class III Directors at the 2026-06-04 meeting.

“Proposal 1. Election of Directors Name of Director Elected For Withheld Broker Non-Votes Diane Parks 44,060,724 14,620,308 11,097,548”

Evolent Health, Inc. shareholders approved Amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan at the 2026-06-04 meeting.

“The Company’s stockholders approved the amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan, as set forth below:”

Evolent Health, Inc. shareholders approved Advisory approval of compensation of named executive officers for 2025 at the 2026-06-04 meeting.

“The Company’s stockholders approved the compensation of our named executive officers for 2025 on an advisory basis, as set forth below:”

Evolent Health, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

“The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 as set forth below:”

Evolent Health, Inc. shareholders approved Election of ten director nominees named in the proxy statement to the Board of Directors for a one-year term expiring at the 2027 annual meeting at the 2026-06-04 meeting.

“The Company’s stockholders elected ten director nominees named in the proxy statement to the Board of Directors for a one-year term expiring at the Company’s 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, as set forth below:”

Trevi Therapeutics, Inc. shareholders approved Amendment to increase authorized shares of common stock from 200,000,000 to 400,000,000 at the 2026-06-03 meeting.

“The Amendment to increase the number of authorized shares of common stock from 200,000,000 shares to 400,000,000 shares was approved. For: 110,453,620 Against: 3,872,599 Abstain: 17,676”

Trevi Therapeutics, Inc. shareholders approved Approval of A&R 2019 Plan at the 2026-06-03 meeting.

“The A&R 2019 Plan was approved. For: 98,140,470 Against: 1,961,030 Abstain: 101,991 Broker Non-Votes: 14,140,404”

Trevi Therapeutics, Inc. shareholders approved Advisory approval of compensation of named executive officers at the 2026-06-03 meeting.

“The compensation of the Company's named executive officers was approved, on an advisory basis. For: 98,119,461 Against: 1,982,126 Abstain: 101,904 Broker Non-Votes: 14,140,404”

Trevi Therapeutics, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-03 meeting.

“The appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2026 was ratified. For: 114,001,970 Against: 223,323 Abstain: 118,602”

Trevi Therapeutics, Inc. shareholders approved Election of Michael Heffernan as Class I director at the 2026-06-03 meeting.

“Michael Heffernan was elected to the Board as a Class I director for a term expiring at the 2029 annual meeting of stockholders. For: 81,567,765 Withheld: 18,635,726 Broker Non-Votes: 14,140,404”

ONESPAWORLD HOLDINGS Ltd shareholders approved Ratification of the appointment of Ernst & Young LLP to serve as the Company's independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-03 meeting.

“Proposal 4. Ratification of the appointment of Ernst & Young LLP to serve as the Company's independent registered public accounting firm for the year ending December 31, 2026: For Against Abstain Broker non-votes 97,197,301 622,401 10,785 0”

ONESPAWORLD HOLDINGS Ltd shareholders approved Approval of OneSpaWorld Holdings Limited Amended and Restated 2019 Equity Incentive Plan at the 2026-06-03 meeting.

“Proposal 3. Approval of OneSpaWorld Holdings Limited Amended and Restated 2019 Equity Incentive Plan: For Against Abstain Broker non-votes 90,153,442 3,881,792 14,391 3,780,862”

ONESPAWORLD HOLDINGS Ltd shareholders approved The approval, by an advisory vote, of the compensation of the Company's named executive officers at the 2026-06-03 meeting.

“Proposal 2. The approval, by an advisory vote, of the compensation of the Company's named executive officers: For Against Abstain Broker non-votes 88,518,672 4,679,736 851,217 3,780,862”

ONESPAWORLD HOLDINGS Ltd shareholders approved Election of Directors at the 2026-06-03 meeting.

“Proposal 1. Election of Directors: Directors For Withheld Broker non-votes Maryam Banikarim 76,395,911 17,653,714 3,780,862 Leonard Fluxman 88,895,160 5,154,465 3,780,862 Glenn J. Fusfield 85,382,478 8,667,147 3,780,862 Adam Hasiba 91,302,823 2,746,802 3,780,862 Andrew R. Heyer 41,524,159 52,525,466 3,780,862 Lisa Myers 80,357,015 13,692,610 3,780,862 Stephen W. Powell 90,857,023 3,192,602 3,780,862”

Pulmonx Corp shareholders approved Non-Binding Advisory Vote to Approve the Company’s Executive Compensation at the 2026-06-04 meeting.

“Proposal 3 – Non-Binding Advisory Vote to Approve the Company’s Executive Compensation The stockholders approved, on a non-binding advisory basis, the Company’s executive compensation as disclosed in the Proxy Statement. The voting results were as follows: For Against Abstain Broker Non-Votes 17,196,362 3,485,784 132,764 11,830,360”

Pulmonx Corp shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows: For Against Abstain 31,458,698 97,509 1,089,063 There were no broker non-votes with respect to Proposal 2.”

Pulmonx Corp shareholders approved Election of three Class III directors at the 2026-06-04 meeting.

“Proposal 1 – Election of Directors The stockholders elected each of the three nominees for Class III director to serve until the Company’s 2029 Annual Meeting of Stockholders and until their successor has been elected and qualified. The voting results were as follows: For Withheld Broker Non-Votes Thomas W. Burns 19,751,638 1,063,272 11,830,360 Georgia Garinois-Melenikiotou 17,680,826 3,134,084 11,830,360 Dana G. Mead, Jr. 19,853,196 961,714 11,830,360”

CarGurus, Inc. shareholders approved Non-binding Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers at the 2026-06-03 meeting.

“The stockholders voted to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers for 2025.”

CarGurus, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-03 meeting.

“The stockholders ratified the appointment of Ernst & Young LLP, an independent registered public accounting firm, as the Company’s independent auditors for the year ending December 31, 2026.”

CarGurus, Inc. shareholders approved Election of Class III Directors at the 2026-06-03 meeting.

“The stockholders elected the nominees named below to serve as the Class III directors for a term ending in 2029, or until their respective successors have been duly elected and qualified.”

Ideal Power Inc. shareholders approved Approval of the Amended and Restated Ideal Power Inc. 2013 Equity Incentive Plan at the 2026-06-03 meeting.

“Proposal 4 — Approval of the Amended and Restated Ideal Power Inc. 2013 Equity Incentive Plan. For Against Abstain Broker Non-Votes 3,624,425 601,975 64,187 2,720,323”

Ideal Power Inc. shareholders approved Non-binding, advisory approval of the compensation of the Company’s named executive officers at the 2026-06-03 meeting.

“Proposal 3 — Approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers. For Against Abstain Broker Non-Votes 3,588,466 625,041 77,080 2,720,323”

Ideal Power Inc. shareholders approved Ratification of the appointment of BPM LLP as the Company’s independent registered public accounting firm at the 2026-06-03 meeting.

“Proposal 2 — Ratification of the appointment of BPM LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain 6,988,321 14,395 8,194”

Ideal Power Inc. shareholders approved Election of five directors to serve until the 2027 annual meeting at the 2026-06-03 meeting.

“Proposal 1 — Election of five directors to serve until the 2027 annual meeting of stockholders and until their respective successors are elected and qualified. Nominee: For Withheld Broker Non-Votes David Somo 4,273,623 16,964 2,720,323 Drue Freeman 4,139,174 151,413 2,720,323 Gregory Knight 4,251,652 38,935 2,720,323 Ted Lesster 4,239,049 51,538 2,720,323 Michael C. Turmelle 4,239,230 51,357 2,720,323”

Aclaris Therapeutics, Inc. shareholders approved Ratification of the selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

“The stockholders ratified the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Aclaris Therapeutics, Inc. shareholders approved Advisory approval of the compensation of the Company’s named executive officers at the 2026-06-04 meeting.

“The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement.”

Aclaris Therapeutics, Inc. shareholders approved Election of two nominees to serve as directors until the 2029 annual meeting at the 2026-06-04 meeting.

“The stockholders elected two nominees to serve as directors on the Board of Directors until the 2029 annual meeting of stockholders and until their respective successors are elected and qualified.”

Heritage Global Inc. shareholders approved Ratify the appointment of UHY LLP as the Company's independent auditor for the fiscal year ending December 31, 2026 at the 2026-06-03 meeting.

“UHY LLP was ratified as the Company's independent auditor for the fiscal year ending December 31, 2026. The results of the vote were as follows: For Against Abstentions Broker Non-Votes 23,370,993 145,179 2,776 0”

Heritage Global Inc. shareholders approved Election of Michael Hexner and William Burnham as Class II directors at the 2026-06-03 meeting.

“Michael Hexner and William Burnham were elected to serve as Class II directors. The results of the election were as follows: For Withheld Broker Non- Votes Michael Hexner 12,393,622 331,369 10,793,957 William Burnham 12,591,056 133,935 10,793,957”

Presurance Holdings, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-03 meeting.

“Proposal No. 2—Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstain 20,542,043 4,882 1,005,954”

Presurance Holdings, Inc. shareholders approved Election of Timothy M. Lamothe and Isolde G. O'Hanlon as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Shareholders at the 2026-06-03 meeting.

“Proposal No. 1— The Election of Timothy M. Lamothe and Isolde G. O'Hanlon, as Class II directors, for a three-year term expiring at the 2029 Annual Meeting of Shareholders Class II Nominee Votes For Votes Withheld Timothy M. Lamothe 19,020,996 340,032 Isolde G. O'Hanlon 19,010,161 350,867”

Pathfinder Bancorp, Inc. shareholders approved Ratification of the appointment of Bonadio & Company, LLP as independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-04 meeting.

“The following table reflects the tabulation of votes with respect to the approval of the ratification of Bonadio & Company, LLP, as our independent registered public accounting firm for the year ending December 31, 2026: For Against Abstain 3,981,917 8,109 5,099”

Pathfinder Bancorp, Inc. shareholders approved Election of four directors, each for a three-year term at the 2026-06-04 meeting.

“The following table reflects the tabulation of votes with respect to the election of the four directors at the 2026 Annual Meeting: Number of Votes For Withheld Non Votes Director nominees for a three-year term: David Ayoub 2,988,385 169,760 836,980 William Barclay 2,966,515 191,630 836,980 James Dowd 3,052,032 106,113 836,980 John Sharkey 2,545,016 613,129 836,980”

SOLAREDGE TECHNOLOGIES, INC. shareholders rejected Amendment to the Company’s Restated Certificate of Incorporation to limit the liability of certain officers as permitted by law at the 2026-06-03 meeting.

“Proposal No. 4 was not approved even though over 89% of the votes cast voted FOR the approval of an exculpation amendment to the Company’s Restated Certificate of Incorporation. This is solely due to the higher applicable voting standard under Delaware law that applies to certificate amendments (majority of outstanding shares as opposed to majority of voting power of the stock, present or represented by proxy and entitled to vote on the matter).”

SOLAREDGE TECHNOLOGIES, INC. shareholders approved Advisory vote to approve the compensation of the Company’s named executive officers at the 2026-06-03 meeting.

“The compensation of the Company’s named executive officers as disclosed in the proxy statement was approved by an advisory vote, as set forth below: Broker For Against Abstain Non-Votes 26,568,856 2,335,161 109,296 6,226,473”

SOLAREDGE TECHNOLOGIES, INC. shareholders approved Ratification of the appointment of Kost Forer Gabbay & Kasierer, a member of EY Global as the Company’s auditors for the year ending December 31, 2026 at the 2026-06-03 meeting.

“The appointment of Kost Forer Gabbay & Kasierer, a member of EY Global as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified by the vote set forth below: Broker For Against Abstain Non-Votes 35,005,162 188,372 46,252 -”

SOLAREDGE TECHNOLOGIES, INC. shareholders approved Election of Mr. Avery More, Ms. Betsy Atkins, Ms. Dana Gross, Mr. Gilad Almogy, Mr. Guy Gecht, Mr. Shuki Nir and Mr. Yoram Tietz as members of the Board of Directors at the 2026-06-03 meeting.

“The following director nominees were elected as directors, each to hold office until the 2027 annual meeting of stockholders and/ or until his or her successor is elected and qualified, by the vote set forth below: Broker For Against Abstain Non-Votes Mr. Avery More 28,203,122 771,824 38,367 6,226,473 Ms. Betsy Atkins 27,469,116 1,510,853 33,344 6,226,473 Ms. Dana Gross 28,305,539 672,144 35,630 6,226,473 Mr. Gilad Almogy 28,919,959 56,558 36,796 6,226,473 Mr. Guy Gecht 28,818,315 157,856 37,142 6,226,473 Mr. Shuki Nir 28,914,278 61,440 37,595 6,226,473 Mr. Yoram Tietz 28,691,944 241,369 80,000 6,226,473”

Climb Global Solutions, Inc. shareholders approved Ratification of the Appointment of Deloitte & Touche, LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026 at the 2026-06-02 meeting.

“Proposal 4: Ratification of the Appointment of Deloitte & Touche, LLP as the Company ' s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026 — The final number of votes cast for, against or abstaining from voting and broker non-votes were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 15,078,115 30,710 30,844 -”